Total Funding
49
41
Total FundingSeed raised
Growth Score 49 in past quarter
-7 pts
Heat Score 41 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
113604
Ousia Pharma focuses on the design and development of pharmacotherapies to improve the health and lives of people living with obesity.
- Christoffer Clemmensen: Co-Founder & CEO
- Anders Bue Klein: Co-Founder & CSO
About the Company
Ousia Pharma is a biotech startup that focuses on the design and development of pharmacotherapies to improve the health and lives of people living with obesity and metabolic diseases. The company uses a targeting approach in which peptides are used to deliver modulators of synaptic plasticity to the brain to drive potent and sustained weight loss
without compromising safety.
It was founded in 2022 and is headquartered in Copenhagen, Denmark.